HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert B Dickson Selected Research

Robert B Dickson Research Topics

Disease

21Neoplasms (Cancer)
09/2009 - 01/2002
15Breast Neoplasms (Breast Cancer)
06/2009 - 01/2002
10Carcinoma (Carcinomatosis)
06/2009 - 01/2002
7Carcinogenesis
08/2008 - 02/2002
6Neoplasm Metastasis (Metastasis)
11/2007 - 05/2002
3Ovarian Neoplasms (Ovarian Cancer)
04/2004 - 04/2002
2Stomach Neoplasms (Stomach Cancer)
12/2006 - 05/2002
2Adenocarcinoma
07/2006 - 02/2006
2Prostatic Neoplasms (Prostate Cancer)
07/2006 - 02/2006
1Thromboembolism
11/2007
1Thyroid Neoplasms (Thyroid Cancer)
05/2006
1Adenoma (Adenomas)
05/2006
1Papillary Carcinoma
05/2006
1Clear Cell Adenocarcinoma
02/2006
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2006
1Prostatic Intraepithelial Neoplasia
02/2006
1Squamous Intraepithelial Lesions
06/2005
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2005
1Lymphatic Metastasis
06/2005
1Lung Neoplasms (Lung Cancer)
06/2005
1Colonic Neoplasms (Colon Cancer)
06/2005
1Blister (Bulla)
10/2003
1Disease Progression
08/2003
1Ovarian Epithelial Carcinoma
04/2002
1Endometrial Neoplasms (Endometrial Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

17matriptaseIBA
11/2007 - 01/2002
10Proteins (Proteins, Gene)FDA Link
05/2006 - 01/2002
9Serine Proteases (Serine Protease)IBA
11/2007 - 04/2002
6HGF activatorIBA
07/2006 - 01/2002
3Epidermal Growth Factor (EGF)IBA
06/2009 - 09/2004
3OligosaccharidesIBA
05/2006 - 05/2002
3DNA (Deoxyribonucleic Acid)IBA
01/2006 - 10/2003
3Glycoproteins (Glycoprotein)IBA
11/2005 - 05/2002
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2004 - 01/2002
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
03/2003 - 01/2002
2CalciumIBA
06/2009 - 09/2004
2Calmodulin (Calcium-Dependent Activator Protein)IBA
06/2009 - 09/2004
2W 7 (W7)IBA
06/2009 - 09/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2009 - 01/2004
2Estrogen ReceptorsIBA
06/2009 - 11/2005
2Messenger RNA (mRNA)IBA
08/2008 - 02/2006
2ErbB Receptors (EGF Receptor)IBA
01/2007 - 11/2005
2Biological ProductsIBA
12/2006 - 05/2002
2Hormones (Hormone)IBA
07/2006 - 02/2002
2alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
05/2006 - 02/2004
2Peptide Hydrolases (Proteases)FDA Link
01/2006 - 01/2002
2Conditioned Culture MediaIBA
06/2005 - 01/2002
2Culture MediaIBA
06/2005 - 01/2004
1PlatinumIBA
09/2009
1LigandsIBA
08/2008
1Phosphotransferases (Kinase)IBA
08/2008
1Small Interfering RNA (siRNA)IBA
08/2008
1ThrombinFDA Link
11/2007
1AnticoagulantsIBA
11/2007
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
12/2006
1SteroidsIBA
07/2006
1Gonadal Steroid Hormones (Sex Hormones)IBA
07/2006
1Uridine Diphosphate (UDP)IBA
05/2006
1MannosidesIBA
05/2006
1AsparagineIBA
05/2006
1AcetylglucosamineIBA
05/2006
1indole-3-carbinolIBA
02/2006
1PhytochemicalsIBA
02/2006
1cytoplasmic antiproteinaseIBA
02/2006
1insulin-like growth factor binding protein-related protein 1IBA
02/2006
1Biomarkers (Surrogate Marker)IBA
02/2006
1SolventsIBA
01/2006
1Cadherins (E-Cadherin)IBA
11/2005
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2005
1ParaffinIBA
06/2005
1Formaldehyde (Formol)FDA Link
06/2005
1TrypsinIBA
06/2005
1Enzyme Precursors (Zymogens)IBA
06/2005
1Benzo(a)pyreneIBA
04/2005
1procyanidinIBA
04/2005
1Cell Cycle ProteinsIBA
04/2005
1saruplaseIBA
04/2004
1Mitochondrial DNA (mtDNA)IBA
03/2004
1Bovine Serum AlbuminIBA
01/2004
1CarcinogensIBA
12/2003
1Dihydrotachysterol (AT 10)IBA
12/2003
1Cytochromes c (Cytochrome c)IBA
10/2003
1Caspase 3 (Caspase-3)IBA
10/2003
1CaspasesIBA
10/2003
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2003
1Apoptosis Inducing FactorIBA
10/2003
1AntibodiesIBA
03/2003
1Proto-Oncogene Proteins c-metIBA
03/2003
1AndrogensIBA
02/2002
1Estrogens (Estrogen)FDA Link
02/2002
1Plasminogen Activators (Plasminogen Activator)IBA
01/2002
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2002

Therapy/Procedure

1Combination Drug Therapy (Combination Chemotherapy)
09/2009
1Therapeutics
11/2007
1Lasers (Laser)
02/2004